Join us September 19-21, 2024 in Bern, Switzerland for the IBCN Annual Meeting. See below for an amazing lineup of topics and speakers!!! Abstract deadline May 31st!! Roland Seiler-Blarer Peter Black Tilman Todenhöfer Kent Mouw Lars Dyrskjøt

We are excited to announce that meeting registration and abstract submission for the 2024 IBCN Annual Meeting in Bern, Switzerland is now OPEN! Please visit ibcnweb.com for all the details. #IBCN2024 Peter Black Tilman Todenhöfer Roland Seiler-Blarer Lars Dyrskjøt Kent Mouw

This was an inspiring talk. We need to keep making progress in this

Join us at AUA Headquarters on March 15-16, 2024 for the seventh annual translational research meeting co-sponsored by the Johns Hopkins Greenberg Bladder Cancer Institute!

Register Now ➡️ bit.ly/47HRag4

Johns Hopkins Greenberg Bladder Cancer Institute Johns Hopkins University

AACR special conference on bladder cancer. I hope to see many of you in Charlotte 17-20 May 2024. Mark you calendars now - we have a strong speaker lineup already

Dan Theodorescu Donna Hansel MD, PhD Tahlita Zuiverloon MD PhD AACR

aacr.org/meeting/aacr-s…

ASCO applauds the appointment of Dr. W. Kimryn Rathmell as the next National Cancer Institute Director. Kimryn Rathmell is a nationally recognized oncologist and experienced leader and we can't wait to work alongside her and the dedicated professionals at NCI. More: brnw.ch/21wExLK

The IBCN board is excited to announce that the 2024 Annual Meeting is scheduled for 19-21 September 2024 in Bern, Switzerland. More details to come in following weeks. #IBCN2024 Lars Dyrskjøt Kent Mouw Roland Seiler-Blarer Tilman Todenhöfer Peter Black

nature.com/articles/s4159…
Sumanta K. Pal, MD, FASCO Sia Daneshmand, M.D. Ronac Mamtani Horowitz Lab @Icahn School of Medicine Mount Sinai Reza Mehrazin, MD Bhardwaj Lab Dr. John Sfakianos Neeraj Agarwal, MD, FASCO Hoosier Cancer Icahn School of Medicine at Mount Sinai Lipschultz Precision Immunology Institute

And of course my favorite person in the world Phillip Abbosh rounding off #ibcn23 experience with uDNA in bladder cancer as marker of residual disease Fox Chase Cancer Center Au revoir Montreal 🇨🇦 it’s been fab

Superb talks by the rising stars in #bladdercancer Trine Strandgaard Gillian Vandekerkhove Eva Michaud Jethro Kwong Jeop de Jong at #IBCN23 IBCN

Congratulations to the winners of best abstract at #IBCN2023 ! Trine Strandgaard, Marie-Pier St-Laurent, and Joep de Jong. Lars Dyrskjøt Peter Black Kent Mouw

All of IBCN would like to thanks Stephen Williams, for his time serving on the IBCN Board and welcome Jeffrey Damrauer as the newest board member. Stephen B. Williams, MD, MBA, MS, FACHE UTMB Health UNC Lineberger

#IBCN23 Dr. Michele Garioni presented organoids, treatments, and sarcomatoid bladder cancer.

#IBCN23 Eva Michaud presented impact of micro biome and immunotherapy in patient with muscle invasive bladder cancer. Wes Kassouf McGill University

#IBCN23 Dr. Jeffrey Damrauer presented meta analysis of GWAS from diverse populations in bladder cancer.

#IBCN23 keynote speaker Dr. Seth Lerner presenting past, present, and future of TCGA and bladder cancer.

Our keynote speaker #IBCN23 Michael Shen discussing bladder cancer organoids investigating lineage plasticity exploiting untapped areas to inform diagnostic and treatment algorithms. Peter Black Lars Dyrskjøt Kent Mouw Tilman Todenhöfer Roland Seiler-Blarer Stephen B. Williams, MD, MBA, MS, FACHE

We thank our sponsors for #IBCN23 in Montreal Sept 28-30 Hyatt Centric. 🙏👍🙌

#IBCN23 SWOG Cancer Research Network 1605 genomic profiling results presented by Marie-Pier St. Laurent Peter Black. Highly variable with bcg resistance having distinct mutational prevalence.

#IBCN23 SURE-01 by Antonio Cigliola neoadjuvant RC outcomes reported safety profile with 50% pCR! Andrea Necchi